3Samis K, Bowley S, Mckersie B. Pyramiding Mn-superoxide dismutase transgenes to improve persistence and biomass production in alfalfa [J]. J Exp Bot, 2002, 53(372): 1343-1350.
4Wigdorovitz A, Mozgovoj M, Santos M J, et al. Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants [J]. J Gen Virol,2004, 85(7): 1825-1832.
5Tuboly T, Yu W, Bailey A, et al. Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants [J]. Vaccine, 2000, 18(19): 2023-2028.
6Dus Santos M J, Wigdorovitz A, Transgenic plants for the production of veterinary vaccines [J]. Immunol Cell Biol, 2005, 83(3): 229-238,
7Wigdorovitz A, Carrillo C, Dus Santos M J, et al. Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VPI [J].Virology, 1999, 255(2): 347-353.
8Dus Santos M J, Wigdorovitz A, Trono K, et al. A novel methodology to develop a foot and mouth disease virus (FMDV)peptide-based vaccine in transgenic plants [J]. Vaccine, 2002, 20(7-8): 1141-1147.
9Dus Santos M J, Carrillo C, Ardila F, et al. Development of transgenic alfalfa plants containing the foot and mouth disease vires structural polyprotein gene PI and its utilization as an experimental immunogen [J]. Vaccine. 2005, 23( 15): 1838-1843.
10Khoudi H, Laberge S, Ferullo J M, et al. Production of a diagnostic monoclonal antibody in perennial alfalfa plants [J].Biotechnol Bioeng. 1999, 64(2): 135-143.